Work

Regulation of ribosome biogenesis by KRAS oncogene in Pancreatic Ductal Adenocarcinoma

Year: 2023
Type: article
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is a cancer of unmet needs, with a 5-year survival rate of only 5%. A key driver mutation in PDAC is KRAS oncogene, found to be mutated in almost all PDAC patients (95%). Previous mouse model studies have demonstrated that mutant KRAS is vital for maintaining PDAC which suggests an ‘addiction’ to KRAS oncogene, although the exact mechanism of this addiction is unknown. To study KRAS oncogene addiction in a systematic manner, a genetically engineered mouse PDAC cell line with an inducible mutant KRAS expression was utilised. Using this model, the global patterns of protein and mRNA expression following mutant KRAS removal, as well as changes in protein translation rates, were examined. This multi-omics analysis demonstrated that KRAS drives ribosome biogenesis, and this was found to be essential in recapitulating KRAS oncogene addiction. The role of LARP1, an RNA-binding protein that can bind to and regulate the translation of Ribosomal Protein coding mRNAs (RP-mRNAs), was initially assessed in this process, and found to be dispensable. Next, an alternative proteomics approach was employed, by performing a quantitative RNA Interactome Capture analysis. This revealed that oncogenic KRAS signalling reshapes the RNA-bound proteomic landscape of cancer cells, with a network of nuclear proteins centred around Nucleolin displaying enhanced RNA-binding activity. It was revealed that Nucleolin is phosphorylated downstream of KRAS, which increases its binding to pre-ribosomal-RNA (rRNA), boosts rRNA production, and promotes ribosome biogenesis. This Nucleolin-dependent enhancement of ribosome biogenesis is crucial for RAS-induced cancer cell proliferation and can be targeted therapeutically to inhibit tumour growth. These results reveal that oncogenic KRAS signalling drives ribosome biogenesis, at least in part, by regulating the RNA-binding activity of Nucleolin, and highlight the crucial role of this process in RAS-mediated tumorigenesis.
Author: Azman, M
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7052171766
FWCI:
Cites: 469
Cited by:
Related to: 10